AbCellera Biologics Inc. (NASDAQ:ABCL) filed its annual report (Form 10-K) with the Securities and Exchange Commission on February 24, 2026. The Healthcare company reported annual…
AbCellera Biologics Inc. (NASDAQ:ABCL) filed its annual report (Form 10-K) with the Securities and Exchange Commission on February 24, 2026.
The Healthcare company reported annual revenue of and net income of for fiscal year 0.
AbCellera Biologics Inc.'s stock currently trades at $3.22 with a market capitalization of $1.1B.
Current market data
NASDAQ · ABCL
$10.46
Down: -$0.59 · -5.34%
Live quote updated
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Keep reading
